{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:57:33Z","timestamp":1758473853335,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1K23AR071473"],"award-info":[{"award-number":["1K23AR071473"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10067-020-05533-2","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T07:03:45Z","timestamp":1610003025000},"page":"809-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-vinculin autoantibodies in systemic sclerosis: a step toward a novel biomarker?"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-2435","authenticated-orcid":false,"given":"Brittany L.","family":"Adler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"5533_CR1","doi-asserted-by":"publisher","first-page":"e000134","DOI":"10.1136\/bmjgast-2017-000134","volume":"4","author":"ER Volkmann","year":"2017","unstructured":"Volkmann ER, Hoffmann-Vold AM, Chang YL, Jacobs JP, Tillisch K, Mayer EA, Clements PJ, Hov JR, Kummen M, Midtvedt \u00d8, Lagishetty V, Chang L, Labus JS, Molberg \u00d8, Braun J (2017) Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterol 4:e000134. https:\/\/doi.org\/10.1136\/bmjgast-2017-000134","journal-title":"BMJ Open Gastroenterol"},{"key":"5533_CR2","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.1097\/MD.0000000000001601","volume":"94","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Gourcerol G, Levesque H, M\u00e9nard JF, Ducrotte P (2015) Fructose malabsorption in systemic sclerosis. Med (United States) 94:e1601. https:\/\/doi.org\/10.1097\/MD.0000000000001601","journal-title":"Med (United States)"},{"key":"5533_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/apt.13810","volume":"44","author":"I Marie","year":"2016","unstructured":"Marie I, Leroi A-M, Gourcerol G, Levesque H, Menard JF, Ducrotte P (2016) Lactose malabsorption in systemic sclerosis. Aliment Pharmacol Ther 44:1123\u20131133. https:\/\/doi.org\/10.1111\/apt.13810","journal-title":"Aliment Pharmacol Ther"},{"key":"5533_CR4","first-page":"80","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80\u201393","journal-title":"Arthritis Res Ther"},{"key":"5533_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI117395","volume":"94","author":"S Howe","year":"1994","unstructured":"Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC Jr (1994) Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 94:761\u2013770. https:\/\/doi.org\/10.1172\/JCI117395","journal-title":"J Clin Invest"},{"key":"5533_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/ard.2008.096545","volume":"68","author":"Y Kawaguchi","year":"2009","unstructured":"Kawaguchi Y, Nakamura Y, Matsumoto I, Nishimagi E, Satoh T, Kuwana M, Sumida T, Hara M (2009) Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis 68:710\u2013714. https:\/\/doi.org\/10.1136\/ard.2008.096545","journal-title":"Ann Rheum Dis"},{"key":"5533_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-2128-z","volume":"22","author":"S Nakane","year":"2020","unstructured":"Nakane S, Umeda M, Kawashiri SY, Mukaino A, Ichinose K, Higuchi O, Maeda Y, Nakamura H, Matsuo H, Kawakami A (2020) Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies. Arthritis Res Ther 22:1\u201310. https:\/\/doi.org\/10.1186\/s13075-020-2128-z","journal-title":"Arthritis Res Ther"},{"key":"5533_CR8","doi-asserted-by":"publisher","unstructured":"Mandal P, Belapurkar V, Nair D, Ramanan N (2020) Vinculin mediated axon growth requires interaction with actin but not talin. bioRxiv 2020.06.29.177758. https:\/\/doi.org\/10.1101\/2020.06.29.177758","DOI":"10.1101\/2020.06.29.177758"},{"key":"5533_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4196\/kjpp.2020.24.2.185","volume":"24","author":"JH Kim","year":"2020","unstructured":"Kim JH, Nam SJ, Park SC, Lee SH, Kim TS, Lee M, Park JM, Choi DH, Kang CD, Lee SJ, Ryu YJ, Lee K, Park SY (2020) Association between interstitial cells of Cajal and anti-vinculin antibody in human stomach. Korean J Physiol Pharmacol 24:185\u2013191. https:\/\/doi.org\/10.4196\/kjpp.2020.24.2.185","journal-title":"Korean J Physiol Pharmacol"},{"key":"5533_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1053\/gast.1996.v111.pm8690216","volume":"111","author":"KM Sanders","year":"1996","unstructured":"Sanders KM (1996) A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 111:492\u2013515. https:\/\/doi.org\/10.1053\/gast.1996.v111.pm8690216","journal-title":"Gastroenterology"},{"key":"5533_CR11","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/gut.2005.086074","volume":"55","author":"CGP Roberts","year":"2006","unstructured":"Roberts CGP, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM (2006) A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 55:1697\u20131703. https:\/\/doi.org\/10.1136\/gut.2005.086074","journal-title":"Gut"},{"key":"5533_CR12","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s10620-017-4585-z","volume":"62","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M (2017) Assessment of Anti-vinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome. Dig Dis Sci 62:1480\u20131485. https:\/\/doi.org\/10.1007\/s10620-017-4585-z","journal-title":"Dig Dis Sci"},{"key":"5533_CR13","doi-asserted-by":"publisher","first-page":"e13875","DOI":"10.1111\/nmo.13875","volume":"32","author":"W Morales","year":"2020","unstructured":"Morales W, Triantafyllou K, Parodi G, Weitsman S, Park SC, Rezaie A, Pichetshote N, Lin E, Pimentel M (2020) Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome. Neurogastroenterol Motil 32:e13875. https:\/\/doi.org\/10.1111\/nmo.13875","journal-title":"Neurogastroenterol Motil"},{"key":"5533_CR14","doi-asserted-by":"publisher","first-page":"e0126438","DOI":"10.1371\/journal.pone.0126438","volume":"10","author":"M Pimentel","year":"2015","unstructured":"Pimentel M, Morales W, Rezaie A, Marsh E, Lembo A, Mirocha J, Leffler DA, Marsh Z, Weitsman S, Chua KS, Barlow GM, Bortey E, Forbes W, Yu A, Chang C (2015) Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One 10:e0126438. https:\/\/doi.org\/10.1371\/journal.pone.0126438","journal-title":"PLoS One"},{"key":"5533_CR15","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1111\/j.1572-0241.2000.03195.x","volume":"95","author":"ES Bonapace","year":"2000","unstructured":"Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP (2000) Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 95:2838\u20132847. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03195.x","journal-title":"Am J Gastroenterol"},{"key":"5533_CR16","first-page":"795","volume":"7","author":"RJ Saad","year":"2011","unstructured":"Saad RJ, Hasler WL (2011) A technical review and clinical assessment of the wireless motility capsule. Gastroenterol Hepatol 7:795\u2013804","journal-title":"Gastroenterol Hepatol"},{"key":"5533_CR17","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1183\/09031936.00181410","volume":"39","author":"H Dib","year":"2012","unstructured":"Dib H, Tamby MC, Bussone G, Regent A, Berezn\u00e9 A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, Humbert M, Mouthon L (2012) Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur Respir J 39:1405\u20131414. https:\/\/doi.org\/10.1183\/09031936.00181410","journal-title":"Eur Respir J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-05533-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T21:22:34Z","timestamp":1613769754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-05533-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5533"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05533-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"12 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This Editorial represents the opinions of the authors and do not reflect those of the National Institutes of Health (NIH) or the National Institute of Arthritis Musculoskeletal and Skin Diseases (NIAMS).Disclosures None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}